21
A Phase I/II, Safety Clinical Trial of DCVAC/PCa and ONCOS-102 in Men With Metastatic Castration-resistant Prostate Cancer
Condition(s):Castration-resistant Prostate CancerLast Updated:February 1, 2021Terminated
Metastatic Prostate Carcinoma in the Soft Tissue: 133 Clinical Trials, Page 3 of 14
Hide Studies Not Open or Pending
22
An Asian Study to Evaluate Efficacy and Safety of Oral Enzalutamide in Progressive Metastatic Prostate Cancer Participants
Condition(s):Progressive Metastatic Prostate CancerLast Updated:March 24, 2021Active, not recruiting
23
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Condition(s):Castration-Resistant Prostatic CancerLast Updated:October 9, 2020Recruiting
24
HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Condition(s):Prostate Cancer Metastatic; Castration-resistant Prostate CancerLast Updated:February 9, 2021Recruiting
25
Ipatasertib Plus Abiraterone Plus Prednisone/Prednisolone, Relative to Placebo Plus Abiraterone Plus Prednisone/Prednisolone in Adult Male Patients With Metastatic Castrate-Resistant Prostate Cancer
Condition(s):Metastatic Prostate CancerLast Updated:March 29, 2021Active, not recruiting
26
imPlementing ROutine Molecular Characterization in Patients With Metastatic Castration Resistant ProstaTe Cancer by NGS
Condition(s):Metastatic Prostate CancerLast Updated:February 9, 2021Recruiting
27
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency
Condition(s):Hormone-Sensitive Prostate CancerLast Updated:April 12, 2021Recruiting
28
18F-FDG PET/CT and Whole Body MRI for Staging and Response Prediction in Castration-resistant Prostate Cancer Patients Receiving Enzalutamide
Condition(s):Prostate Cancer MetastaticLast Updated:February 21, 2021Completed
29
Sipuleucel-T With or Without Radiation Therapy in Treating Patients With Hormone-Resistant Metastatic Prostate Cancer
Condition(s):Adenocarcinoma of the Prostate; Bone Metastases; Hormone-resistant Prostate Cancer; Recurrent Prostate Cancer; Soft Tissue Metastases; Stage IV Prostate CancerLast Updated:August 25, 2020Completed
30
PROMOTE: Identifying Predictive Markers of Response for Genitourinary Cancer
Condition(s):Prostate Cancer; Advanced Renal Cell Carcinoma; Advanced Urothelial Carcinoma; Genitourinary CancerLast Updated:December 22, 2020Recruiting